SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurochem (NRMX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: pcyhuang who wrote (45)6/7/2007 2:50:30 PM
From: enigma7   of 54
 
Saw this morning that one of the Analysts that writes research on Neurochem is suggesting that this Monday they will be releasing the long awaited results for Alzhemed. The analyst was not very positive at all, but is the same analyst that covers Allon, a junior Alzheimer's company in Canada who he appears to have a lot more faith in and I have recently become a follower of. Will be interesting news for the sector on Monday, as Paul Aisen is scheduled to give his report.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News